Abstract:Pathogenic hantaviruses, genus Orthohantaviridae, are maintained in rodent reservoirs with zoonotic transmission to humans occurring through inhalation of rodent excreta. Hantavirus disease in humans is characterized by localized vascular leakage and elevated levels of circulating proinflammatory cytokines. Despite the constant potential for deadly zoonotic transmission to humans, specific virus-host interactions of hantaviruses that lead to innate immune activation, and how these processes impart disease, remain unclear. In this study, we examined the mechanisms of viral recognition and innate immune activation of Hantaan orthohantavirus (HTNV) infection. We identified the RIG-I-like receptor (RLR) pathway as essential for innate immune activation, interferon (IFN) production, and interferon stimulated gene (ISG) expression in response to HTNV infection in human endothelial cells, and in murine cells representative of a non-reservoir host. Our results demonstrate that innate immune activation and signaling through the RLR pathway depends on viral replication wherein the host response can significantly restrict replication in target cells in a manner dependent on the type 1 interferon receptor (IFNAR). Importantly, following HTNV infection of a non-reservoir host murine model, IFNAR-deficient mice had higher viral loads, increased persistence, and greater viral dissemination to lung, spleen, and kidney compared to wild-type animals. Surprisingly, this response was MAVS independent in vivo. Innate immune profiling in these tissues demonstrates that HTNV infection triggers expression of IFN-regulated cytokines early during infection. We conclude that the RLR pathway is essential for recognition of HTNV infection to direct innate immune activation and control of viral replication in vitro, and that additional virus sensing and innate immune response pathways of IFN and cytokine regulation contribute to control of HTNV in vivo. These results reveal a critical role for innate immune regulation in driving divergent outcomes of HTNV infection, and serve to inform studies to identify therapeutic targets to alleviate human hantavirus disease.Human pathogenic hantaviruses are endemic in rodent reservoir hosts worldwide. Incidental pathogenic human hantavirus infection has a case-fatality rate of up to 38%. Although Hantaan orthohantavirus (HTNV) is a major cause of human hemorrhagic fevers in Asia, the mechanisms underlying innate immune activation in human target endothelial cells remain unknown. Here, we find that the host cytoplasmic pathogen recognition receptors, RIG-I and MDA5, are essential for induction of antiviral proteins and control of HTNV replication in human and non-reservoir murine cells. Type I interferon, but not type III interferon, is induced in response to live virus infection, and can limit HTNV replication in these cells. We further demonstrate that type I interferon signaling is required for rapid control of virus replication and dissemination in non-reservoir murine hosts in vivo. Importantly, a role for type I interferon-independent mechanisms of antiviral induction in vivo was also revealed. This work provides deeper understanding of how differential host responses to HTNV infection contribute to infection outcomes and is essential to identify targets for therapeutic interventions to mitigate human hantavirus disease.

Differential Antagonism of Human Innate Immune Responses by Tick-Borne Phlebovirus Nonstructural Proteins

Title Differential Antagonism of Human Innate Immune Responses byTick-Borne Phlebovirus Nonstructural Proteins

Antiviral RNA interference in disease vector (Asian longhorned) ticks

The Tick Saliva Peptide HIDfsin2 TLR4-Dependently Inhibits the Tick-Borne Severe Fever with Thrombocytopenia Syndrome Virus in Mouse Macrophages

Heartland Virus Epidemiology, Vector Association, and Disease Potential

The Tick Protein Sialostatin L2 Binds To Annexin A2 And Inhibits Nlrc4-Mediated Inflammasome Activation

Tick Extracellular Vesicles Enable Arthropod Feeding and Promote Distinct Outcomes of Bacterial Infection

Rhipicephalus simus ticks: new hosts for phleboviruses

The Ecology of New Constituents of the Tick Virome and Their Relevance to Public Health

Severe fever with thrombocytopenia syndrome virus infection shapes gut microbiome of the tick vector Haemaphysalis longicornis

Towards modelling tick-virus interactions using the weakly pathogenic Sindbis virus: Evidence that ticks are competent vectors

Selection Pressure Profile Suggests Species Criteria among Tick-Borne Orthoflaviviruses

Differential Macrophage Phenotype Rewired by Hantaan Virus Constrains the Magnitude of Inflammatory Responses in Murine Versus Humans

The tick saliva peptide HIDfsin2 promotes the tick-borne virus SFTSV replication in vitro by enhancing p38 signal pathway

Transcriptional Response to Tick-Borne Flavivirus Infection in Neurons, Astrocytes and Microglia In Vivo and In Vitro

Current insights into human pathogenic phenuiviruses and the host immune system

Exploration of binary protein–protein interactions between tick-borne flaviviruses and Ixodes ricinus

Comparative Pathogenesis of Two Lineages of Powassan Virus Reveals Distinct Clinical Outcome, Neuropathology, and Inflammation

RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication

Differential susceptibility of geographically distinct Ixodes ricinus populations to tick-borne encephalitis virus and louping ill virus

Modeling Heartland virus disease in mice and therapeutic intervention with 4′-fluorouridine